Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.0 / 5 stars · 28/71 Roast Me

PALATIN TECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares.
  • PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was -41.86K shares.
  • PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 0.00 shares.
  • PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 43.60K shares.
  • PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 1.74K shares.
  • PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 0.00 shares.
  • PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares.
  • PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was -270.50K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2023-09-300.00 shares
10-Q · filed 2023-11-14
2022-06-30-41.86K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
1.74K shares
10-K · filed 2023-09-28
2022-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16
2021-12-3143.60K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14
2021-09-300.00 shares
10-Q · filed 2021-11-15
2021-06-300.00 shares
10-K · filed 2021-09-28
2020-06-300.00 shares
10-K · filed 2021-09-28
2019-06-30-270.50K shares
10-K · filed 2020-09-25
2018-06-30-208.90K shares
10-K · filed 2020-09-25
2014-06-300.00 shares
10-K · filed 2014-09-12
2013-06-300.00 shares
10-K · filed 2014-09-12
2012-06-300.00 shares
10-K · filed 2014-09-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B